We are investigating the safety and effectiveness of belantamab for treating multiple myeloma, both on its own and with other therapies. This study aims to find out how well it works for patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Multiple myeloma is a cancer that forms in a type of white blood cell called plasma cells, which help fight infections by making antibodies. In this condition, abnormal plasma cells accumulate in the bone marrow, leading to various health issues.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.